CSIMarket Company Name, Ticker, Competitors, else..
 

Healthcare Sector

Major Pharmaceutical Preparations Industry Profitability  


Profitability by Company within Major Pharmaceutical Preparations Industry
Company Quarter Gross Margin Net Margin Cash flow Margin ROE
Abcellera Biologics Inc 1 Q - 53.25% 22.27% 19.72%
Abeona Therapeutics Inc 1 Q - -6008.96% -3645.09% -145.51%
Abbott Laboratories 1 Q 58.07% 20.57% -17.86% 22.02%
Arbutus Biopharma Corp 1 Q - -125.31% -222.18% -53.43%
Abvc Biopharma Inc. 1 Q 92.61% -23724.14% -12208.21% -294.28%
Acadia Pharmaceuticals Inc 1 Q 97.45% -97.91% 49.78% -40.52%
Acer Therapeutics Inc. 1 Q - - - -
Acelrx Pharmaceuticals Inc 1 Q -77.38% -1962.44% - -
Acura Pharmaceuticals inc 3 Q - -97.04% -28.89% -
Acurx Pharmaceuticals inc 1 Q - - - -
Adc Therapeutics Sa 4 Q 95.89% -678.2% - -138.5%
Adial Pharmaceuticals Inc. 1 Q - - - -232.78%
Adamis Pharmaceuticals Corp 1 Q -26.77% -896.88% -472.32% -132.77%
Adamas Pharmaceuticals Inc 3 Q 97.78% -75.37% -39.29% -
Aditxt Inc. 1 Q 10.56% -2881.48% -2737.72% -71.62%
Advaxis Inc. 1 Q - -976% -3858% -29.54%
Aeterna Zentaris Inc 4 Q 98.29% -159.09% - -15.79%
Affimed N v 4 Q - -142.5% - -42.31%
Agex Therapeutics Inc 4 Q 96.3% -7996.3% -114.81% -
Agios Pharmaceuticals Inc 1 Q 59.25% -11391.11% -14795.67% -25.95%
Aeglea Biotherapeutics Inc 1 Q - -1794.13% -37.81% -78.56%
Agile Therapeutics Inc 1 Q 13.29% -668.31% -874.5% -588%
Aimmune Therapeutics Inc 2 Q - - - -170.95%
Akebia Therapeutics Inc 1 Q 49.2% -101.17% 41.83% -266.13%
Akcea Therapeutics Inc 2 Q 93.66% -221.55% -123.23% -8.94%
Akero Therapeutics Inc 1 Q - - - -60.85%
Akorn Inc 2 Q 25.81% -57.07% 9.11% -62.97%
Akari Therapeutics Plc 4 Q - - - -185.67%
Akouos inc 1 Q - - - -40.01%
Albireo Pharma inc. 1 Q 96.57% -621.11% -460.36% -21.15%
Aldeyra Therapeutics Inc 1 Q - - - -29.78%
Alimera Sciences Inc 1 Q 85.88% -50.05% -55.18% -
Alkermes Plc 1 Q 80.2% -12.89% -19.74% -5.63%
Allakos Inc 1 Q - - - -91.36%
Allogene Therapeutics Inc 1 Q - -130901.64% -145573.77% -32.28%
Alnylam Pharmaceuticals Inc 1 Q 89% -112.7% -134.06% -137.44%
Alpine Immune Sciences Inc 1 Q - -55.23% -242.26% -46.87%
Alexion Pharmaceuticals Inc 1 Q 92.34% 29.89% 28.84% 4.69%
Alx Oncology Holdings Inc 1 Q - - - -25.07%
Alzamend Neuro Inc 4 Q - - - -
Amag Pharmaceuticals inc 3 Q 85.67% 20.78% -0.58% -69.3%
Ampio Pharmaceuticals inc. 1 Q - - - -87.38%
Amphastar Pharmaceuticals Inc 1 Q 46.38% 20.15% 38.44% 18.35%
Amarin Corp Plcuk 1 Q 76.5% -33.35% -0.32% -3.42%
Amneal Pharmaceuticals Inc 1 Q 35.08% -1.3% -8.08% -0.22%
Applied Molecular Transport Inc 1 Q - - - -71.26%
Anaptysbio inc 1 Q - -3737.63% -33950.21% -20.84%
Arctos Northstar Acquisition Corp. 1 Q - - - -
Anebulo Pharmaceuticals Inc 1 Q - - - -
Ani Pharmaceuticals inc 1 Q 46.85% -31.22% -36.28% -24.05%
Anixa Biosciences Inc. 1 Q - - - -37.37%
Annexon Inc 1 Q - - - -56.31%
Annovis Bio inc 1 Q - - - -37.83%
Apellis Pharmaceuticals Inc 1 Q - -966.1% -46.87% -607.37%
Applied Therapeutics Inc 1 Q - - - -137.7%
Aptinyx Inc 1 Q - - - -77.57%
Aquestive Therapeutics Inc 1 Q 65.66% -107.74% -108.3% -
Aravive Inc 1 Q - -1195.7% - -88.49%
Arcturus Therapeutics Holdings Inc 1 Q - -975.76% -968.99% -81.21%
Aridis Pharmaceuticals inc. 1 Q - -654.25% -483.91% -
Ardelyx inc 1 Q 81.84% -5998.08% -5416.88% -177.07%
Arena Pharmaceuticals Inc 4 Q - -288164.81% -300150% -69.83%
Arcutis Biotherapeutics Inc 1 Q - - - -70.62%
Array Technologies Inc 1 Q 8.85% -7.34% -105.85% -
Arvinas Inc 1 Q - -18.6% -190.08% -21.27%
Ascendis Pharma A 4 Q 54.71% -4931.56% - -43.41%
Assertio Holdings inc 1 Q 88.52% 24.81% 67.27% 3.21%
Athersys Inc 1 Q - 0% -536.06% 0%
180 Life Sciences Corp. 1 Q - - - -8.54%
Actinium Pharmaceuticals Inc 1 Q - -545.64% -618.09% -32.44%
Athenex Inc 1 Q 21.63% -60.33% -148.04% -215.36%
Adhera Therapeutics Inc. 1 Q - - - -
Avenue Therapeutics inc. 1 Q - - - -439.43%
Astria Therapeutics inc 1 Q - - - -51.74%
Aurinia Pharmaceuticals Inc 1 Q 98.82% -174.01% -459.46% -43.2%
Avadel Pharmaceuticals Plc 1 Q - - - -102.82%
Aveo Pharmaceuticals Inc 1 Q 88.37% -48.75% 15.79% -85.29%
Atea Pharmaceuticals Inc 1 Q - - - 7.54%
Aerovate Therapeutics Inc. 1 Q - - - -8.86%
Avalo Therapeutics Inc 1 Q 38.62% -1879.88% -1369.74% 38.54%
Axsome Therapeutics Inc 1 Q - - - -389.74%
Astrazeneca Plc 4 Q 66.76% 0.31% 16.91% 0.29%
Bridgebio Pharma Inc 1 Q - -11884.89% -1308.85% -
Atreca inc 1 Q - - - -65.05%
Bicycle Therapeutics Plc 1 Q - -714.09% -811.11% -31.61%
Biodelivery Sciences International Inc 4 Q 84% - 31.51% 63.64%
Biofrontera Inc 1 Q - 30.12% -11.47% 0%
Beigene Ltd 1 Q 78.72% -141.63% -9.27% -40.1%
Bausch Health Companies Inc 1 Q 71.69% -3.44% 17.78% -
Biohaven Pharmaceutical Holding Company Ltd 1 Q 91.74% -36.66% 0.01% -
Biovie Inc 1 Q - - - 174.44%
Bioxytran Inc. 1 Q - - - -
Bellicum Pharmaceuticals Inc 1 Q - -54014.29% -45621.43% -155.67%
Bellerophon Therapeutics inc 1 Q - - - -76.59%
Biolinerx Ltd 4 Q - - - -39.73%
Biomea Fusion Inc. 1 Q - - - -28.27%
Biomerica Inc 1 Q 21.84% -1.36% 38.83% -156.03%
Biomarin Pharmaceutical Inc 1 Q 77.48% 23.26% 3.5% 0.92%
Bristol myers Squibb Company 1 Q 78.79% 11.01% -14.91% 17.68%
Benitec Biopharma Inc. 1 Q - -6822.92% -7706.25% -127.37%
Blueprint Medicines Corporation 1 Q 9.68% -167.79% -273.14% -58.75%
Bespoke Extracts Inc. 1 Q 72.33% -31770.47% -1760.73% -
Biospecifics Technologies Corp 3 Q - 47.86% -124.36% 13.39%
Bioxcel Therapeutics Inc 1 Q - - - -52.26%
Beyondspring Inc 4 Q - -5048.7% -5026.79% -326%
Calithera Biosciences Inc 1 Q - - - -266.85%
Can fite Biopharma Ltd 4 Q - -1175.26% -454.63% -69.71%
Cymabay Therapeutics Inc 1 Q - - - -92.27%
Chemocentryx Inc 1 Q 98.12% -353.62% -86.11% -47.24%
Avid Bioservices Inc. 1 Q 22.37% - -76.19% 156.25%
Celularity Inc 1 Q 92.01% -1059.26% - -105.6%
Chembio Diagnostics Inc 1 Q 19.09% -46.72% -23.24% -123.38%
Contrafect Corporation 1 Q - - - -74.27%
Chiasma Inc 1 Q 96.52% -1587.73% - -113.57%
Checkpoint Therapeutics inc 1 Q - -32400% -25498.08% -222.54%
Clene Inc 1 Q - -44513.33% -124526.67% -
Cellectar Biosciences Inc 1 Q - - - -67.56%
Clearside Biomedical Inc 1 Q - -2202.88% - 0.31%
Celsion Corporation 1 Q - -8379.47% - -41.93%
Clever Leaves Holdings Inc 1 Q 39.01% -308.96% - -20.07%
Clovis Oncology inc 1 Q 76.44% -175.69% -61.87% -
Chemomab Therapeutics Ltd 1 Q - - - 25.18%
Compass Pathways Plc 1 Q - - - -25.75%
Chimerix inc. 1 Q -660% -165113.33% - -118.41%
Concert Pharmaceuticals Inc 1 Q - - - -170.61%
Cns Pharmaceuticals Inc 1 Q - - - -25.94%
Constellation Pharmaceuticals Inc 1 Q - - - -33.12%
Centessa Pharmaceuticals Plc 1 Q - - - -10.35%
Context Therapeutics Inc 1 Q - - - 0%
Cogent Biosciences Inc 1 Q - - - -44.91%
Collegium Pharmaceutical inc 1 Q 40.75% -10.98% -66.99% 18.95%
Corcept Therapeutics Inc 1 Q 98.67% 24.33% -16.82% 24.23%
China Pharma Holdings Inc 1 Q -10.56% -64.18% -71.34% -59.21%
Cumberland Pharmaceuticals Inc 1 Q 80.21% -12.55% -87.46% -11.58%
Catalyst Pharmaceuticals Inc 1 Q 86.33% 30.73% 16.08% 22.12%
Corbus Pharmaceuticals Holdings Inc 1 Q - - - -54.78%
Cormedix Inc 1 Q 80% -92118.83% -103862.83% -41.7%
Crinetics Pharmaceuticals Inc 1 Q - -1105.94% -1761.32% -46.36%
Corvus Pharmaceuticals Inc 1 Q - - - -44.21%
Cti Biopharma Corp 1 Q 87.89% -1619.83% - -616.49%
Innovation Pharmaceuticals Inc 1 Q - - - -111.74%
Catalent Inc 1 Q 33.23% 11.08% -8.64% 10.64%
Cure Pharmaceutical Holding Corp. 1 Q 68% -467% 46.69% 0%
Cohbar Inc. 1 Q - - - -17.48%
Celyad Oncology Sa 4 Q - - - -60.75%
Cyclacel Pharmaceuticals Inc 1 Q - - - -50.16%
Cyclerion Therapeutics Inc 1 Q - -1825.32% -1805.34% -99.04%
Cytokinetics Incorporated 1 Q - -7791.38% - -164.73%
Dar Bioscience Inc 1 Q - - - -145.59%
Day One Biopharmaceuticals Inc 1 Q - - - -9.65%
Decibel Therapeutics Inc 1 Q - - - -37.06%
Journey Medical Corporation 1 Q 64.79% -5.92% -33.27% -127.12%
Dice Therapeutics Inc 1 Q - - - 0%
Diamedica Therapeutics Inc 1 Q - - - -35.43%
Dermata Therapeutics Inc 1 Q - - - -37.22%
Dicerna Pharmaceuticals Inc 3 Q - -27.12% -88.09% -103.08%
Durect Corp 1 Q 82.51% -566.16% -21.1% -60.89%
Design Therapeutics Inc 1 Q - - - -11.2%
Dynavax Technologies Corp 1 Q 64.94% 28.83% -225.26% 63.02%
Edesa Biotech Inc 1 Q - - - -123.27%
Effector Therapeutics Inc 1 Q - - - 188.89%
Zyla Life Sciences 1 Q 81.66% -95.66% -95.86% -234.08%
Eagle Pharmaceuticals inc 1 Q 78.27% 38.02% -24.28% 18.56%
Elanco Animal Health Inc 1 Q 58.45% 3.92% -24.16% -4.71%
Eledon Pharmaceuticals Inc 1 Q - - - -21.43%
Elite Pharmaceuticals Inc. 1 Q 45.05% 31.66% 16.25% 40.81%
Eliem Therapeutics Inc. 1 Q - - - -11.79%
Endo International Plc 1 Q 58.11% -11.03% -5.58% -
Enlivex Therapeutics Ltd 4 Q - - - -17.01%
Enochian Biosciences Inc 1 Q - - - -24.27%
Ensysce Biosciences Inc 1 Q - -157.67% -634.02% -
Enanta Pharmaceuticals Inc 1 Q - -179.48% -310.32% -28.8%
Enveric Biosciences Inc 1 Q - - - -166.21%
Evolus Inc 1 Q 61.05% -51.61% -116.74% -80.2%
Essa Pharma inc 4 Q - -12198.22% -22480.56% -28.02%
Epizyme Inc 1 Q 69.68% -638.28% -240.51% -1287.29%
Eqrx Inc 1 Q - - - 2.67%
Erasca Inc 3 Q - - - -
Esperion Therapeutics Inc 1 Q - -301.18% -310.72% -
Eton Pharmaceuticals Inc. 1 Q 67% -244.94% 37.82% -73.59%
Entasis Therapeutics Holdings Inc 1 Q - - - -145.48%
Evofem Biosciences Inc 1 Q 74.92% -752.03% -137.76% -
Evoke Pharma Inc 1 Q - -519.54% -345.02% -199.81%
Edgewise Therapeutics inc 1 Q - - - 0%
Fortress Biotech Inc 1 Q 65.71% -206.8% -76.21% -85.54%
Forte Biosciences Inc. 1 Q - - - -44.47%
Fibrogen Inc 1 Q 93.03% -103.91% 24.12% -109.09%
Foghorn Therapeutics Inc 1 Q - -686.58% - -118.78%
Flexion Therapeutics Inc 3 Q 82.52% -142.14% - -
Fresenius Medical Care Ag and Co Kgaa 4 Q 28.82% 6.92% 6.14% 8.72%
Amicus Therapeutics inc 1 Q 90.37% -108.31% -14.78% -95.05%
Five Prime Therapeutics Inc 4 Q - - - -54.86%
F star Therapeutics Inc 1 Q - -473.81% -381.65% -35.82%
Fitlife Brands Inc 3 Q 43.92% 16.78% 2.86% 46.29%
Fulcrum Therapeutics Inc 1 Q - -1000.31% -80.98% -48.38%
First Wave Biopharma Inc. 1 Q - - - -
Galectin Therapeutics Inc. 1 Q - - - -857.75%
Gain Therapeutics inc 1 Q - -7271.57% -5649.26% -40.43%
Generation Bio Co 1 Q - - - -32.65%
Gb Sciences Inc 1 Q - - - -
Global Blood Therapeutics Inc 1 Q 98.09% -147.61% -531% -129.74%
Geron Corp 1 Q - -24469.92% -2883.74% -85.84%
Guardion Health Sciences Inc 4 Q 40.48% -552.63% 20.17% -69.84%
Galmed Pharmaceuticals Ltd 4 Q - - - 106.46%
Galapagos Nv 4 Q 99.66% -21.29% 0% -3.91%
Gelesis Holdings Inc 1 Q 34.62% -77.07% 74.37% -
Galecto Inc 1 Q - - - -45.22%
Glycomimetics Inc 1 Q - - - -55.48%
Gemini Therapeutics Inc 1 Q - - - -50.88%
Generex Biotechnology Corp 1 Q -218.89% - - -
Genprex Inc 1 Q - - - -44%
Graybug Vision Inc 1 Q - - - -50.75%
Gracell Biotechnologies Inc 4 Q - - - -24.72%
Grifols Sa 4 Q - - - 3.63%
Glaxosmithkline Plc 4 Q 65.99% 14.94% 12.53% 23.88%
Globestar Therapeutics Corporation 1 Q - - - -
Gt Biopharma Inc. 1 Q - - - -165.24%
Gw Pharmaceuticals Plc 1 Q 92.26% -12.91% -18.79% -2.83%
Hutchmed china Limited 4 Q 35.57% -46.9% 79.02% -16.07%
Hcw Biologics Inc 1 Q 57.4% -65.99% - -6.26%
Hepion Pharmaceuticals inc 1 Q - - - -34.19%
Humanigen inc 1 Q - -2053.86% -103.09% -
Hookipa Pharma inc. 1 Q - -1243.46% - -63.59%
Hoth Therapeutics Inc 1 Q - - - -105.89%
Werewolf Therapeutics Inc 1 Q - - - -36.02%
Health right Discoveries Inc 3 Q 81.21% -121.6% -69.65% -
Harmony Biosciences Holdings inc 1 Q 82.75% 25.18% -11.5% 28.66%
Harrow Health Inc 1 Q 73.04% -11.02% -0.99% -138.33%
Heron Therapeutics Inc 1 Q 51.59% -272.36% -143.37% -243.86%
Histogen Inc 1 Q - -18.22% -22.29% -54.31%
Horizon Therapeutics Public Limited Company 1 Q 75.71% 23.07% 7.13% 19.14%
Ibio inc 4 Q 32.74% -7095.24% -10520.83% -28.09%
Intercept Pharmaceuticals inc 1 Q 99.14% -19.51% -39.44% -
Ideaya Biosciences Inc 1 Q - -123.36% -323.58% -19.08%
I mab 4 Q 47.25% -2648.74% -1403.18% -51.14%
Immunogen inc 1 Q - -63.41% -107.91% -66.56%
Imago Biosciences Inc 1 Q - - - -11.74%
Immutep Ltd 2 Q - -753.57% - -40.81%
Immunome inc 2 Q - - - -40.28%
Impel Pharmaceuticals Inc. 1 Q 41.27% -1533.26% - -178.04%
Imara inc 1 Q - - - -59.32%
Immuron Limited 2 Q 64.97% -5751.61% - -32.38%
Immuneering Corp 1 Q 50.55% -7020.42% - -12.19%
Immunic Inc 1 Q - - - -59.64%
Indaptus Therapeutics Inc 4 Q - - - 0%
Inmed Pharmaceuticals Inc 1 Q 58.88% -1122.69% -1738.34% 0%
Insmed Inc 1 Q 77.04% -178.17% -378.63% -111.77%
Inspire Medical Systems inc 1 Q 85.58% -24.06% -16.11% -19.02%
Innoviva Inc 1 Q - 42.04% 16.96% 60.5%
Inozyme Pharma Inc 1 Q - - - -53.41%
Io Biotech Inc. 1 Q - - - 0%
Ionis Pharmaceuticals Inc 1 Q 97.06% -45.92% -230.19% -0.6%
Intellipharmaceutics International Inc 4 Q - -241.95% 9.81% -
Ironwood Pharmaceuticals inc 1 Q - 39.78% -27.44% 122.32%
Iveric Bio Inc 1 Q - - - -46.15%
Intra cellular Therapies Inc 1 Q - -206.08% - -53.93%
Jaguar Health inc 1 Q 82.67% -691.96% 15.43% -320.63%
Janux Therapeutics Inc 1 Q - -843.93% - -3.61%
Jazz Pharmaceuticals Plc 4 Q - -51.45% -58.56% -23.6%
Johnson and Johnson 1 Q 67.57% 21.98% -17.18% 27.49%
Kala Pharmaceuticals inc. 1 Q - -2400.95% -2114.29% -369.16%
Kalvista Pharmaceuticals Inc 4 Q - - - -31.24%
Kyto Technology And Life Science Inc 4 Q - - - 13.86%
Kadmon holdings inc 3 Q 95.63% -232.46% 47.23% -216.92%
Chinook Therapeutics Inc 1 Q - -1174.79% -2900.41% -26.93%
Kindred Biosciences Inc 2 Q 81.93% -258.07% - -54.55%
Kamada Ltd 4 Q 29.26% -2.15% 0% -1.26%
Kempharm Inc 1 Q - -47.01% -306.03% -0.1%
Kiniksa Pharmaceuticals Ltd 1 Q 86.89% -78.32% -183.75% -66.73%
Kinnate Biopharma Inc 1 Q - - - -8.17%
Kiora Pharmaceuticals inc 4 Q - - - -131.92%
Karyopharm Therapeutics Inc 1 Q - -86.84% -89.24% -
Kronos Bio Inc 1 Q - - - -43.43%
Keros Therapeutics Inc 1 Q - - - -29.12%
Karuna Therapeutics Inc 1 Q - - - -33.73%
Kintara Therapeutics Inc 1 Q - - - -721.02%
Pasithea Therapeutics Corp. 1 Q 5.28% -11526.14% -19369.6% 0%
Kura Oncology Inc 1 Q - - - -25.49%
Khosla Ventures Acquisition Co 1 Q - - - -
Landos Biopharma Inc 1 Q - - - -51.46%
Longboard Pharmaceuticals Inc 1 Q - - - -29.74%
Lannett Company Inc 1 Q 3.93% -44.54% 9.54% -
Legend Biotech Corporation 4 Q - -430.12% - -81.96%
Lexaria Bioscience Corp 1 Q 79.16% -4651.8% -8347.22% -34.81%
Lifevantage Corp 1 Q 80.69% 2.28% -4.76% 26.43%
Ligand Pharmaceuticals Incorporated 1 Q 74.15% -33.67% -9.91% 2.94%
Longeveron Inc 1 Q 81.08% -948.65% -952.97% -11.82%
Lianbio 1 Q - - - 0%
Lftd Partners Inc 1 Q 44.14% 16.28% 16.48% 30.2%
Eli Lilly And Company 1 Q 73.47% 24.36% -17.4% 73.77%
Liminal Biosciences Inc 4 Q - - - 36.05%
Lipocine Inc 1 Q - - - -1.93%
Leap Therapeutics inc 1 Q - - - -47.38%
Larimar Therapeutics Inc 1 Q - - - -72.75%
Lantern Pharma Inc 1 Q - - - 0%
Lumos Pharma Inc 1 Q - -6954.95% -7253.15% -32.26%
Lexicon Pharmaceuticals Inc 1 Q - - - -75.21%
Lyell Immunopharma Inc 1 Q - -12322.6% -12914.83% -7.14%
Merrimack Pharmaceuticals Inc 1 Q - - - -20.89%
Marizyme Inc. 1 Q - - - -28.8%
Mustang Bio inc 4 Q - - - -68.56%
Moleculin Biotech Inc 1 Q - - - -23.07%
Seres Therapeutics Inc 1 Q - -3792.63% -1783.32% -70.91%
Medavail Holdings Inc 1 Q 5.5% -142.88% -155.13% -191.44%
23andme Holding Co. 1 Q 46.8% -69.16% -32.84% -27.2%
Mei Pharma Inc. 3 Q - -225.73% 91.25% -112.21%
Macrogenics Inc 1 Q 99.57% -598.53% -685.89% -84.52%
Magenta Therapeutics Inc. 1 Q - - - -42.77%
Mirum Pharmaceuticals Inc 1 Q - -283.94% - -73.5%
Milestone Pharmaceuticals Inc 1 Q - - - -36.93%
Stealth Biotherapeutics Corp 4 Q - - - -
Moonlake Immunotherapeutics 1 Q - - - -61.8%
Mallinckrodt Plc 1 Q 35.79% -24.36% 4.18% -
Mannkind Corporation 1 Q 27.33% -216.79% -474.82% -
Mallinckrodt Plc 1 Q 35.79% -24.36% 4.18% -154.21%
Medicinova Inc 1 Q - - - -15.7%
Monopar Therapeutics Inc 1 Q - - - -12.2%
Morphosys Ag 4 Q 82.08% -286.43% 61.13% -210.09%
Morphic Holding inc 1 Q - -1321.75% -2165.91% -31.37%
Mereo Biopharma Group Plc 4 Q 50.89% 34.9% 64.36% 14.46%
Merck and Co Inc 1 Q 66.17% 27.12% 2.81% 38.23%
Marker Therapeutics inc 1 Q - -1027.72% -1522.13% -88.13%
Marinus Pharmaceuticals Inc 1 Q 91.76% -136.48% 23.91% -136.1%
Mersana Therapeutics inc 1 Q - -2321.12% - -119.1%
Mirati Therapeutics Inc 1 Q - -26570.66% -15287.31% -52.23%
Maravai Lifesciences Holdings Inc 1 Q 83.61% 60.12% -49.04% 108.79%
Metacrine Inc 1 Q - - - -112.65%
Molecular Templates Inc 1 Q - - -75.55% 110.16%
Midatech Pharma Plc 4 Q - -944.64% 0% -52.24%
Mylan N v 3 Q 38.98% 6.25% 11.52% 2.25%
Myovant Sciences Ltd 1 Q 93.72% -102.98% -88.66% -
Nature s Sunshine Products inc 1 Q 68.81% -2.43% -17.78% 15.43%
Nabriva Therapeutics Plc 1 Q 58.09% -147.37% -173.02% -82.07%
Neubase Therapeutics inc 1 Q - - - -70.88%
Nanobiotix S a 4 Q - -1775.71% - -175.45%
Novabay Pharmaceuticals Inc 1 Q 57.66% -4.22% -83.15% -36.44%
Nucana Plc 4 Q - - - -61.84%
Neos Therapeutics Inc 3 Q 59.15% -39.18% 0.52% -
Neptune Wellness Solutions Inc 1 Q -6.22% -205.77% 33.2% -42.37%
Minerva Neurosciences inc 1 Q - - - -284.62%
Neximmune Inc 1 Q - - - -63.55%
Ngm Biopharmaceuticals Inc 1 Q - -154.91% -200.13% -36.46%
Nighthawk Biosciences inc. 1 Q - -3855.51% - -30.54%
Nektar Therapeutics 1 Q 78.59% -364.16% - -65.63%
Nkarta Inc 1 Q - - - -35.72%
9 Meters Biopharma Inc. 1 Q - - - -94.39%
Nanomix Corp 1 Q - - - -
Novan Inc. 1 Q 89.32% -693.98% -601.3% -165.01%
Neurobo Pharmaceuticals Inc 1 Q - - - -140.86%
Nurix Therapeutics Inc 1 Q - -442.09% -11.55% -38.11%
Nrx Pharmaceuticals Inc. 1 Q - - - -3283.94%
Rebus Holdings Inc 1 Q - - - -
Intec Pharma Ltd 1 Q - - - -96.37%
Neurotrope inc 3 Q - - - 46.07%
Nuvation Bio Inc 1 Q - - - -11.59%
Novartis Ag 4 Q 69.99% 45.42% 18.27% 35.41%
Northwest Biotherapeutics inc 1 Q - -3527.05% -2036.23% -
Nextcure Inc 1 Q - - - -30.63%
Obseva Sa 4 Q - -290.25% - -180.52%
Ocular Therapeutix Inc 1 Q 90.14% -95.11% -142.16% -26.5%
Ocuphire Pharma Inc 1 Q - - - -117.53%
Oragenics Inc 1 Q - -40014.55% -39072.07% -61.04%
Organon and Co 1 Q 64.2% 22.21% -2.74% -
Olema Pharmaceuticals inc 1 Q - - - -27.06%
Omeros Corporation 1 Q - - - -
Oncorus Inc 1 Q - - - -50.39%
Oncosec Medical Incorporated 1 Q - - - -150.2%
Oncolytics Biotech Inc 4 Q - - - -72.87%
Onconova Therapeutics inc 4 Q - -2076.6% - -53.42%
Opko Health Inc 1 Q 32.81% -16.84% -9.85% -6.85%
Optinose Inc 1 Q 86.36% -171.63% -129.65% -
Organogenesis Holdings Inc 1 Q 74.44% 0.09% -6.14% 39.86%
Oric Pharmaceuticals Inc 1 Q - - - -31.74%
Oramed Pharmaceuticals Inc 1 Q - - 76.73% 25.72%
Orphazyme A 4 Q - -1731.11% - -100.97%
Otonomy Inc 1 Q - - - -86.69%
Oncotelic Therapeutics Inc 4 Q - - - -113.41%
Ovid Therapeutics Inc 1 Q - -1114.46% -1461.88% -38.63%
Phibro Animal Health Corp 1 Q 29.89% 7.38% 3.07% 24.05%
Pandion Therapeutics Inc 4 Q - - - 0%
Prestige Consumer Healthcare Inc 1 Q 55.77% -55.97% 2.31% 13.75%
Panbela Therapeutics Inc 1 Q - - - -127.71%
Puma Biotechnology Inc 1 Q 76.29% -7.44% -17.64% -844.14%
Pacira Biosciences inc 1 Q 77.17% 4.32% -227.12% 5.4%
Processa Pharmaceuticals Inc. 1 Q - - - -42.39%
Pds Biotechnology Corp 1 Q - - - -34.38%
Pfizer Inc 1 Q 61.09% 30.67% 2.06% 32.65%
Pfenex Inc 2 Q 12.93% -1322.79% -584.64% -11.41%
Progenics Pharmaceuticals Inc 1 Q 75.06% -268.9% -206.16% -129.46%
Pharming Group N v 4 Q 89.37% 8.04% - 8.29%
Phasebio Pharmaceuticals Inc. 1 Q - -9522.22% -19753.85% -
Phio Pharmaceuticals Corp 1 Q - - - -52.46%
Pharvaris N v 4 Q - - - -20.85%
Pliant Therapeutics Inc 1 Q - -2249.8% -1530.82% -48.97%
Plx Pharma Inc 1 Q 43.88% -517.76% -810.99% -130.17%
Pmv Pharmaceuticals Inc 1 Q - - - -20.48%
Point Biopharma Global Inc 1 Q - - - -31.55%
One World Products Inc. 1 Q 1.88% -5942.25% -337.76% -
Purple Biotech Ltd 4 Q - - - 28.37%
Propanc Biopharma Inc. 1 Q - - - -
Praxis Precision Medicines Inc 1 Q - - - -77.8%
Pardes Biosciences Inc 1 Q - - - -16.86%
Perrigo Company Plc 1 Q 31.44% -0.22% 8.02% 2.85%
Principia Biopharma Inc 2 Q - 21.62% - 0%
Prophase Labs Inc 1 Q 60.33% 26.29% 36.08% 32.04%
Proqr Therapeutics N v 4 Q - - - 0%
Prothena Corporation Public Limited Company 1 Q - -3147.44% -3130.96% 16.02%
Paratek Pharmaceuticals Inc 1 Q 85.95% -72.04% -125.53% -
Provention Bio Inc 1 Q - -3787.59% -565.52% -83.66%
Ptc Therapeutics inc 1 Q - -85.2% -30.62% -983.21%
Portola Pharmaceuticals inc 1 Q 83.63% -260.6% -68.57% -273.08%
Palatin Technologies Inc 1 Q 78.29% -3531.56% -4445.23% -95.87%
Provectus Biopharmaceuticals Inc. 1 Q - -549.52% -333.64% -
Pyxis Oncology Inc 1 Q - - - 0%
Qualigen Therapeutics Inc 1 Q - -598.28% -543.94% -139.46%
Uniqure N v 1 Q - -2604.8% -1745.2% 54.85%
Rain Therapeutics Inc 1 Q - - - -44.51%
Rani Therapeutics Holdings Inc 1 Q - - - -15.2%
Ultragenyx Pharmaceutical Inc 1 Q 92.37% -190.55% -191.88% -51.89%
Rasna Therapeutics Inc. 1 Q - - - -
Rocket Pharmaceuticals Inc 1 Q - - - -37.21%
Redhill Biopharma Ltd 4 Q 42.39% - 34.16% 1101.34%
Radius Health inc 1 Q 90.13% -42.35% -92.49% -
Dr Reddys Laboratories Ltd 1 Q 53.08% 11% 0% 13.14%
Regeneron Pharmaceuticals Inc 1 Q 93.01% 32.83% 15.55% 44.65%
Reliv International Inc 3 Q 73.58% -1.44% 7.03% -1.53%
Reata Pharmaceuticals Inc 1 Q - -8078.99% -6376.26% -137.52%
Revelation Biosciences Inc. 1 Q - - - -
Regulus Therapeutics Inc 1 Q - - - -77.06%
Rigel Pharmaceuticals Inc 1 Q 99.28% -164% 34.59% -219.06%
Rallybio Corporation 1 Q - - - 0%
Avidity Biosciences Inc 1 Q - -1907.24% -10080% -36.26%
Transcode Therapeutics Inc. 1 Q - - - -25%
Renovorx Inc 1 Q - - - 0%
Roivant Sciences Ltd. 1 Q - -2313.9% -896.93% 0%
Reneo Pharmaceuticals Inc 1 Q - - - -30.08%
Repare Therapeutics Inc 1 Q - - - -47.6%
Rvl Pharmaceuticals Plc 1 Q 90% -31.81% -65.77% -10.13%
Revance Therapeutics Inc 1 Q 56.01% -254.71% - -483.19%
Reviva Pharmaceuticals Holdings Inc. 1 Q - - - -51.14%
Prometheus Biosciences Inc 1 Q - -818.22% -771.12% -43.92%
Rhythm Pharmaceuticals inc 4 Q 87.01% -2359.16% -1823% -20.79%
Rezolute Inc 1 Q - - - -94.24%
Sage Therapeutics Inc 1 Q 81.92% -7715.23% -7304.61% -27.23%
Cassava Sciences Inc 1 Q - - - -17.93%
Silverback Therapeutics Inc 1 Q - - - -29.56%
Scopus Biopharma Inc 1 Q - - - -3421.76%
Societal Cdmo Inc 1 Q 23.97% -20.12% -46.9% -23.33%
Scynexis inc 1 Q - -793.45% -1349.93% -89.64%
Seelos Therapeutics Inc 1 Q - -53850% -65238.46% -94.26%
Sesen Bio Inc 1 Q - - - 7.73%
Sigilon Therapeutics Inc 1 Q - -437.88% -1347.74% -83.44%
Siga Technologies Inc 1 Q 55.21% -3.43% - 49.46%
Sio Gene Therapies Inc. 1 Q - - - -82.33%
Skye Bioscience Inc 1 Q - - - -194.19%
Sellas Life Sciences Group Inc 1 Q 89.89% -1693.02% -718.2% -166.08%
Summit Therapeutics Inc 1 Q - -8558.8% - -111.36%
Sonoma Pharmaceuticals Inc 4 Q 41.45% -32.53% 4.72% -71.16%
Synaptogenix Inc 1 Q - - - 10.18%
Sensei Biotherapeutics Inc 1 Q - - - -27.48%
Sanofi 4 Q 67.47% 33.05% 25.23% 19.56%
Sonnet Biotherapeutics Holdings Inc 1 Q - -8611.52% -6057.69% -118.71%
Spectrum Pharmaceuticals Inc 1 Q - - - -190.29%
Spruce Biosciences Inc 1 Q - - - -38.29%
Scisparc Ltd 4 Q - - - 71.11%
Sarepta Therapeutics Inc 1 Q - -49.82% -418.34% -52.06%
Sierra Oncology Inc 1 Q - - - -76.49%
Statera Biopharma Inc fka Cytocom Inc 3 Q 50.99% -5383.61% - -56.39%
Stemline Therapeutics Inc 1 Q 92.78% -239.99% - -48.14%
Stoke Therapeutics Inc 1 Q - -821.63% -2026.13% -39.42%
Supernus Pharmaceuticals inc 1 Q 88.24% 16.8% -57.52% 9.05%
Sinovac Biotech Ltd 4 Q 94.47% 74.63% 54.55% 104.2%
Savara Inc 1 Q - - - -27.33%
Synlogic Inc 1 Q - -6433.2% - -43.07%
Synthetic Biologics inc. 1 Q - - - -23.05%
Syros Pharmaceuticals inc. 1 Q - -459.96% -415.71% -101.54%
Takeda Pharmaceutical Company Limited 1 Q - - - 3.62%
Taro Pharmaceutical Industries Ltd 1 Q 54.04% -73% 16.73% -23.64%
Theravance Biopharma inc 1 Q - -196.62% 33.4% -
Tricida Inc 1 Q - - - -
Alaunos Therapeutics Inc. 1 Q - - - -101.43%
Terns Pharmaceuticals Inc. 1 Q - - - -30.55%
Teva Pharmaceutical Industries Ltd 1 Q 47.53% -26% 1.42% -5.24%
Tff Pharmaceuticals Inc 1 Q - -12420.85% -10944.62% -19.29%
Thorne Healthtech Inc 1 Q 55.09% 8.62% -36.03% 0%
Theseus Pharmaceuticals inc 1 Q - - - 0%
Taiwan Liposome Company Ltd 4 Q - -964.68% - -113.89%
Teligent Inc 2 Q -25.91% -123.32% -47.14% -
Tiziana Life Sciences Ltd 4 Q - - - -37.54%
Timber Pharmaceuticals Inc 1 Q - -3695% -3544.57% -179.6%
Tango Therapeutics Inc 1 Q - -437.79% -714.22% -9.74%
Tonix Pharmaceuticals Holding Corp 1 Q - - - -48.46%
Tempest Therapeutics Inc 1 Q - - - -72.31%
Turning Point Therapeutics Inc 1 Q - -17353.15% -27586.71% -28.04%
Entrada Therapeutics Inc 1 Q - - - 0%
Trillium Therapeutics Inc 3 Q - - - 15.79%
Trevi Therapeutics inc 1 Q - - - -232.27%
Trevena inc 1 Q -935% -81945% -91295% -82.39%
2seventy Bio Inc 1 Q 93.94% -1016.86% - 0%
Titan Pharmaceuticals inc. 1 Q - -1322.92% - -142.58%
Tetraphase Pharmaceuticals Inc 1 Q 22.51% -690.83% - -210.86%
Travere Therapeutics Inc 1 Q 95.59% -156.68% - -70.33%
Therapeuticsmd Inc 1 Q 74.86% -253.56% -179.68% -
Tyme Technologies Inc. 1 Q - - - -26.64%
Tyra Biosciences Inc 1 Q - - - 0%
Unicycive Therapeutics Inc 1 Q - - - -31.78%
United Therapeutics Corporation 1 Q 94.39% 51.94% -17.64% 17.62%
Vaccitech Plc 1 Q - 17.14% -89.61% -13.29%
Vaxxinity Inc 1 Q - - - 0%
Vascular Biogenics Ltd 4 Q 52.47% - - 59.15%
Vaccinex Inc. 1 Q - - - -155.64%
Vera Therapeutics Inc. 1 Q - - - -47.14%
Verve Therapeutics Inc 1 Q - - - -8.16%
Viela Bio Inc 3 Q - -1625.43% -859.33% -18.16%
Vincerx Pharma Inc 1 Q - - - -54.69%
Viracta Therapeutics Inc 1 Q - - - 0%
Viking Therapeutics Inc 1 Q - - - -27.77%
Vallon Pharmaceuticals Inc 1 Q - - - -134.01%
Vanda Pharmaceuticals Inc 1 Q 90.59% -10.68% 24.68% 3.65%
Verrica Pharmaceuticals Inc 1 Q - -1965.2% - -112.86%
Verona Pharma Plc 1 Q - - - -39.61%
Virpax Pharmaceuticals Inc. 1 Q - - - -17.26%
Vertex Pharmaceuticals Inc 1 Q 88.28% 36.33% 38.33% 24.67%
Verastem Inc 1 Q - -653.39% - -84.99%
Viatris Inc 1 Q 42.25% 9.52% 1.22% 0.81%
Vtv Therapeutics Inc 1 Q - -471.2% -63.85% -
Ventyx Biosciences Inc 1 Q - - - 0%
Vyne Therapeutics Inc 1 Q - - - 96.49%
World Health Energy Holdings Inc. 1 Q - -5029.8% - -
Xbiotech Inc 1 Q 57.4% -1079% -1032.4% -6.99%
Exicure Inc 1 Q - -325.46% -731.15% -324.25%
Xenon Pharmaceuticals Inc 1 Q - -220.98% -674.73% -20.31%
Xeris Biopharma Holdings Inc 1 Q 71.58% 1.85% - -398.29%
Xilio Therapeutics inc 1 Q - - - 0%
Xencor Inc 1 Q - 27.6% -76.28% 15.74%
Xoma Corporation 1 Q - -73.38% -217.06% 23.33%
Xtl Biopharmaceuticals Ltd 4 Q - - - -14.66%
Y mabs Therapeutics inc 1 Q 82.54% -267.67% -236.89% -59.67%
Yumanity Therapeutics Inc 1 Q - -1308.02% -1866.28% -162.54%
Zogenix Inc 4 Q 93.83% - -18.63% -91.2%
Zentalis Pharmaceuticals Inc 1 Q - - - -56.08%
Zosano Pharma Corporation 1 Q 34.85% -25309.85% - -172.07%
Zoetis Inc 1 Q 71.35% 29.91% -17.62% 45.41%
Zynerba Pharmaceuticals Inc. 1 Q - - - -50.04%
Profitability
Major Pharmaceutical Preparations Industry
Gross margin improved to 66.18 % in 1. Quarter 2022 from 65.9 % in previous quarter, now Ranking #25 and ranking within sector #2.
Net margin for Major Pharmaceutical Preparations Industry is 20.97 % above industry average.

More on Major Pharmaceutical Preparations Industry Profitability

Major Pharmaceutical Preparations Industry achieved cash flow margin of 9.96 % and above average return on equity of 15.5 %

More on Major Pharmaceutical Preparations Industry Cash flow
More on Major Pharmaceutical Preparations Industry ROE







Cardiovascular Segment
Revenues Income
14.75% -7.45% 23.14% -12.12%
Y/Y Q/Q Y/Y Q/Q

Neuroscience Segment
Revenues Income
14.75% -7.45% 23.14% -12.12%
Y/Y Q/Q Y/Y Q/Q

Anti-Infective Segment
Revenues Income
14.75% -7.45% 23.14% -12.12%
Y/Y Q/Q Y/Y Q/Q

Respiratory Segment
Revenues Income
14.75% -7.45% 23.14% -12.12%
Y/Y Q/Q Y/Y Q/Q

Arthritis & Pain Segment
Revenues Income
24.3% 7.73% - -
Y/Y Q/Q Y/Y Q/Q

Urology Segment
Revenues Income
9.97% 1.68% - -
Y/Y Q/Q Y/Y Q/Q

Oncology Segment
Revenues Income
9.97% 1.68% - -
Y/Y Q/Q Y/Y Q/Q

Endocrine Segment
Revenues Income
-34.8% -30.47% - -
Y/Y Q/Q Y/Y Q/Q




       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

 Stocks


Event Calendar

JILL's Profile

Stock Price

JILL's Financials

Business Description

Fundamentals

Charts & Quotes

JILL's News

Suppliers

JILL's Competitors

Customers & Markets

Economic Indicators

JILL's Growth

Company Segments

 Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness
Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

 Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies
Help


Sitemap

Advertise

About us

 Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071